Latest P/E ratio for QSAM Biosciences: -6.69 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-6.69
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
QSAM Biosciences (QSAM) currently reports a P/E ratio of -6.69. That is below the Materials sector average of 24.82. Use the charts on this page to explore QSAM Biosciences's P/E ratio history and peer comparisons.
QSAM Biosciences's P/E ratio of -6.69 is lower than the Materials sector average of 24.82. That is roughly 127.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates QSAM Biosciences's market price to a fundamental measure such as earnings, sales, or book value. At -6.69, QSAM can look expensive or cheap only in context — versus its own history, growth rate, and Materials peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -6.69, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 24.82. From there, open related valuation or income-statement pages for QSAM Biosciences, and consider following QSAM for alerts when major investors trade the stock.
QSAM Biosciences is classified in the Materials sector. On P/E ratio, it currently shows -6.69 versus a sector average near 24.82. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing QSAM with unrelated industries.